Get started
KLARIA PHARMA HOLDING AB BTAKLARIA PHARMA HOLDING AB BTAKLARIA PHARMA HOLDING AB BTA

KLARIA PHARMA HOLDING AB BTA

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

KLAR_BTA chart


Full chart

KLAR_BTA upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪174.11 M‬ SEK
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.278 SEK
Net income (FY)
‪−47.75 M‬ SEK
Revenue (FY)
‪2.25 M‬ SEK
Shares float
—
Beta (1Y)
3.22

Employees


Employees (FY)
4
Change (1Y)
−2 −33.33%
Revenue / Employee (1Y)
‪562.00 K‬ SEK
Net income / Employee (1Y)
‪−11.94 M‬ SEK

About KLARIA PHARMA HOLDING AB


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Scott Boyer
Website
klaria.com
Headquarters
Uppsala
Founded
2014
ISIN
SE0025196850
FIGI
BBG01V885K22
Klaria Pharma Holding AB engages in the development and commercialization of pharmaceutical products for migraine and cancer-related pain. Its operation is based on a patented drug delivery platform in an alginate-based polymer film. The firm's project portfolio currently includes various pain states, opioid overdoses, cannabinoids, and allergic shock. The company was founded by Scott Boyer and Fredrik Hübinette in 2015 and is headquartered in Uppsala, Sweden.

Check out other big names from the same industry as KLAR_BTA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

KLAR_BTA news



Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of KLAR_BTA is 0.550 SEK — it has decreased by −7.09% in the past 24 hours. Watch KLARIA PHARMA HOLDING AB BTA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange KLARIA PHARMA HOLDING AB BTA stocks are traded under the ticker KLAR_BTA.
KLAR_BTA stock has risen by 37.50% compared to the previous week, the month change is a −38.89% fall, over the last year KLARIA PHARMA HOLDING AB BTA has showed a −38.89% decrease.
KLAR_BTA reached its all-time high on Dec 22, 2022 with the price of 1.500 SEK, and its all-time low was 0.382 SEK and was reached on Jul 10, 2025. View more price dynamics on KLAR_BTA chart.
See other stocks reaching their highest and lowest prices.
KLAR_BTA stock is 11.70% volatile and has beta coefficient of 3.22. Track KLARIA PHARMA HOLDING AB BTA stock price on the chart and check out the list of the most volatile stocks — is KLARIA PHARMA HOLDING AB BTA there?
Today KLARIA PHARMA HOLDING AB BTA has the market capitalization of ‪177.80 M‬, it has increased by 15.51% over the last week.
Yes, you can track KLARIA PHARMA HOLDING AB BTA financials in yearly and quarterly reports right on TradingView.
KLARIA PHARMA HOLDING AB BTA is going to release the next earnings report on Aug 28, 2025. Keep track of upcoming events with our Earnings Calendar.
KLAR_BTA net income for the last quarter is ‪−1.59 M‬ SEK, while the quarter before that showed ‪−15.58 M‬ SEK of net income which accounts for 89.78% change. Track more KLARIA PHARMA HOLDING AB BTA financial stats to get the full picture.
No, KLAR_BTA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 19, 2025, the company has 4 employees. See our rating of the largest employees — is KLARIA PHARMA HOLDING AB BTA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KLARIA PHARMA HOLDING AB BTA EBITDA is ‪−6.86 M‬ SEK, and current EBITDA margin is −892.62%. See more stats in KLARIA PHARMA HOLDING AB BTA financial statements.
Like other stocks, KLAR_BTA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KLARIA PHARMA HOLDING AB BTA stock right from TradingView charts — choose your broker and connect to your account.